Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of Macromolecules

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Pharmaceutical Research

• Publication date

  2003-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1023/B:PHAM.0000003390.51761.3dPMID 14661937
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Pharmaceutical Industry Perspective

  2004influential reference
• Workshop on Bioanalytical Methods Validation for Macromolecules: Summary Report

  2001cited by this paper
• Statistical Methods for Assessing Stability of Compounds in Whole Blood for Clinical Bioanalysis

  2001cited by this paper
• Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective.

  2000influential reference
• Bioanalytical Method Validation—A Revisit with a Decade of Progress

  2000cited by this paper
• Measuring agreement in method comparison studies

  1999cited by this paper
• The SFSTP guide on the validation of chromatographic methods for drug bioanalysis: from the Washington Conference to the laboratory

  1999cited by this paper
• Points of care in using statistics in method comparison studies.

  1998cited by this paper
• Reappraisal of hypothesis testing for method validation : detection of systematic error by comparing the means of two methods or of two laboratories

  1995cited by this paper
• Determination of parallelism and nonparallelism in bioassay dilution curves

  1994cited by this paper
• Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies

  1992cited by this paper
• Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies

  1991cited by this paper
• Summary of the Report

  1987influential reference
• A new approach for dealing with the stability of drugs in biological fluids.

  1985cited by this paper
• β-Expectation and β-Content Tolerance Limits for Balanced One-Way ANOVA Random Model

  1984cited by this paper
• Kinetics of two-site immunoradiometric ('sandwich') assays-I. Mathematical models for simulation, optimization, and curve fitting.

  1978cited by this paper
• Kinetics of two-site immunoradiometric ('sandwich') assays-II. Studies on the nature of the 'high-dose hook effect'.

  1978cited by this paper
• THE DESIGN OF OPTIMUM MULTIFACTORIAL EXPERIMENTS

  1946cited by this paper

• Implementation of the fully automated diagnostic immunoanalyzer cobas e411 in the bioanalytical laboratory - Lessons learnt.

  2026cites this paper
• Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results from a Randomized, Open‐Label, Parallel‐Group Study

  2026cites this paper
• A Review on: Bioanayltical Method Development and Validation

  2025cites this paper
• Influence of process parameters on single-cell oil production by Cutaneotrichosporon oleaginosus using response surface methodology

  2025cites this paper
• Response to Response to Letter Regarding “Plasma Concentration of Thrombopoietin in Dogs With Immune Thrombocytopenia”

  2025cites this paper
• Oxytocin: a neglected hormone in pituitary disease - From function to the diagnosis of a deficiency, resulting clinical relevance, and potential treatment options in endocrinology

  2025cites this paper
• Interleukin-6 moderates the relationship between social support, strain, and future depressive symptoms

  2025cites this paper
• Exploring the relationship between plasma and salivary levels of oxytocin, vasopressin, and cortisol in beagles: A preliminary study.

  2025cites this paper
• Evaluation of singlicate vs duplicate analysis in ligand binding assays: a case study with IFN-γ in mouse and NHP models.

  2025cites this paper
• Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines

  2025cites this paper
• Effects of gastrointestinal parasites on fecal glucocorticoids and behaviour in vervet monkeys (Chlorocebus pygerythrus)

  2025cites this paper
• Immunocapture LC–MS Methods for Pharmacokinetics of Large Molecule Drugs

  2024cites this paper
• Improved enzyme-linked immunosorbent assay using surface-adhesive antibody-oriented immobilizing biolinker: a proof-of-concept study

  2024cites this paper
• Immunoassays and Mass Spectrometry for Determination of Protein Concentrations in Genetically Modified Crops

  2024cites this paper
• Validation of high-sensitivity assays to quantitate cerebrospinal fluid and serum β-galactosidase activity in patients with GM1-gangliosidosis

  2024cites this paper
• Screening Non-neutralizing Anti-idiotype Antibodies Against a Drug Candidate for Total Pharmacokinetic and Target Engagement Assay

  2024cites this paper
• Case Studies on the use of Microsampling for Nonclinical Studies in Pharmaceutical Drug Discovery and Development

  2024cites this paper
• Introduction to qualification and validation of an immunoassay

  2024cites this paper
• Comprehensive Analysis of Cetuximab Critical Quality Attributes: Impact of Handling on Antigen-Antibody Binding

  2024cites this paper
• Letter regarding “Plasma concentration of thrombopoietin in dogs with immune thrombocytopenia”

  2024cites this paper
• MB09, a denosumab biosimilar candidate: Biosimilarity demonstration in a phase I study in healthy subjects

  2024cites this paper
• Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy

  2024cites this paper
• Population Pharmacokinetics of Epcoritamab Following Subcutaneous Administration in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

  2024cites this paper
• PHARMACEUTICAL AND CLINICAL CHALLENGES OF BIOLOGICAL MEDICINES: ONGOING HURDLES FROM DRUG DEVELOPMENT TO THERAPEUTIC APPLICATIONS

  2024cites this paper
• Whole Blood Theophylline Measurements Using an Electrochemical DNA Aptamer-based Biosensor

  2024cites this paper
• Validation of a newly developed immunoassay for TDP-43 in human plasma

  2024influential citation
• Best Practices for Development and Validation of Enzymatic Activity Assays to Support Drug Development for Inborn Errors of Metabolism and Biomarker Assessment

  2024cites this paper
• Depression, Inflammation, and the Moderating Role of Metformin: Results From the Midlife in the United States Study and Sacramento Area Latino Study on Aging

  2023cites this paper
• Development of an Indirect Enzyme-Linked Immunosorbent Assay Based on the Yeast-Expressed CO-26K-Equivalent Epitope-Containing Antigen for Detection of Serum Antibodies against Porcine Epidemic Diarrhea Virus

  2023cites this paper
• Pharmacokinetic Similarity of ABP 654, an Ustekinumab Biosimilar Candidate: Results from a Randomized, Double‐blind Study in Healthy Subjects

  2023cites this paper
• Noncompetitive immunoassay optimized for pharmacokinetic assessments of biologically active efruxifermin.

  2023cites this paper
• Automated Bioanalytical Workflow for Ligand Binding-Based Pharmacokinetic Assay Development.

  2023cites this paper
• Comprehensive physicochemical and functional analysis of pembrolizumab based on controlled degradation studies: Impact on antigen-antibody binding.

  2023cites this paper
• Biomarkers have to make sense.

  2023cites this paper
• Analyzer-to-Analyzer Variations in Assaying Ultralow Concentrated Biomarkers Associated with Neurodegenerative Diseases Using Immunomagnetic Reduction

  2023cites this paper
• Quantification of chondroitin sulfate, hyaluronic acid and N-glycans in synovial fluid – A technical performance study

  2023cites this paper
• Step-by-step full factorial design to optimize a quantitative sandwich ELISA.

  2023cites this paper
• Ultrasensitive, Multiplexed Buoyant Sensor for Monitoring Cytokines in Biofluids

  2023cites this paper
• BIOANALYTICAL METHOD VALIDATION: A COMPREHENSIVE ASSESSMENT OF VARIOUS REGULATORY GUIDELINES

  2023cites this paper
• Quantifying Huntingtin Protein in Human Cerebrospinal Fluid Using a Novel Polyglutamine Length-Independent Assay

  2022cites this paper
• Improvements to Hybridization-Ligation ELISA Methods to Overcome Bioanalytical Challenges Posed by Novel Oligonucleotide Therapeutics

  2022influential citation
• Development of a 36-Channel Instrument for Assaying Biomarkers of Ultralow Concentrations Utilizing Immunomagnetic Reduction

  2022cites this paper
• Advances in human oxytocin measurement: challenges and proposed solutions

  2022cites this paper
• Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress

  2022cites this paper
• How low is really low? Comparison of two C‐peptide assays to establish residual C‐peptide production in type 1 diabetes

  2022cites this paper
• Continuous Method Validation: Beyond One-Time Studies to Characterize Analytical Methods

  2022cites this paper
• Evaluation of Stress Accompanying Immunocontraceptive Vaccination in Donkeys

  2022cites this paper
• Is Incurred Sample Reanalysis (ISR) Applicable in Biomarker Assays?

  2022cites this paper
• Technical performance of a proximity extension assay inflammation biomarker panel with synovial fluid

  2022cites this paper
• A liquid crystal-based biosensor for detection of insulin driven by conformational change of an aptamer at aqueous-liquid crystal interface.

  2022cites this paper
• An engineered (CAGA)12-EGFP cell-based biosensor for high-content and accurate detection of active TGF-β.

  2022cites this paper
• Validation of a Commercial Enzyme-Linked Immunosorbent Assay for Allopregnanolone in the Saliva of Healthy Pregnant Women

  2022influential citation
• Multiplex Hybrid Antigen-Capture LC-MRM Quantification in Sera and Nasal Lining Fluid of AZD7442, a SARS-CoV-2-Targeting Antibody Combination

  2022cites this paper
• The Selectivity of Immunoassays and of Biomimetic Binding Assays with Imprinted Polymers

  2021cites this paper
• Full validation of an ELISA for quantification of antibodies against Haemophilus influenzaetype b capsular polysaccharide

  2021cites this paper
• Murine monoclonal antibodies against RBD of the SARS-CoV-2 spike protein as useful analytical tools for subunit vaccine development and clinical trials

  2021cites this paper
• High-Throughput Flow-Through Direct Immunoassays for Targeted Bacteria Detection.

  2021cites this paper
• Factors affecting the stability of drugs and their metabolites in biological matrices

  2021cites this paper
• How Families Make Their Way Into Your Heart: Exploring the Associations Between Daily Experiences Involving Family Members and Cardiovascular Health.

  2021cites this paper
• A cell-based alternative to the mouse potency assay for pharmaceutical type E botulinum antitoxins.

  2021influential citation
• Investigation of the Number of Tests Required for Assaying Plasma Biomarkers Associated with Alzheimer’s Disease Using Immunomagnetic Reduction

  2021cites this paper
• Method and Clinical Validation of Biomarkers for Neurodegenerative Diseases

  2021cites this paper
• Development of an Indirect ELISA Based on Spike Protein to Detect Antibodies against Feline Coronavirus

  2021cites this paper
• Microwell Plate-Based Dynamic Light Scattering as a High-Throughput Characterization Tool in Biopharmaceutical Development

  2021cites this paper
• The Selectivity of Molecularly Imprinted Polymers

  2021cites this paper
• Simultaneous electrochemical detection of ciprofloxacin and Ag(I) in a silver nanoparticle dissolution: Application to ecotoxicological acute studies

  2021cites this paper
• Bayesian calibration, process modeling and uncertainty quantification in biotechnology

  2021cites this paper
• Concentración de metano ruminal en Bos primigenius taurus Linnaeus: modelo de medición in vitro

  2021cites this paper
• A selective and sensitive UPLC-ESI-MS/MS method for quantification of Pegylated Interferon Alfa-2b in human serum using signature peptide-based quantitation.

  2021cites this paper
• Bioanalytical method development and validation of highly selective and sensitive LC-MS/MS method for determination of teriparatide (parathyroid hormone fragment 1-34) in human serum through direct detection of intact teriparatide molecule.

  2021cites this paper
• Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis

  2020cites this paper
• Antibody Subunit LC-MS Analysis for Pharmacokinetic and Biotransformation Determination from In-Life Studies for Complex Biotherapeutics.

  2020cites this paper
• Automated, generic reagent and ultra-targeted 2D-LC-MS/MS enabling quantification of biotherapeutics and soluble targets down to pg/mL range in serum.

  2020cites this paper
• Development and validation of a new IgE-Tolerant ELISA method for quantifying serum concentration of omalizumab.

  2020cites this paper
• Inflammation, depression, and anxiety disorder: A population-based study examining the association between Interleukin-6 and the experiencing of depressive and anxiety symptoms.

  2020cites this paper
• Recommendations for singlet-based approach in ligand binding assays: an IQ Consortium perspective.

  2020cites this paper
• Method validation

  2020cites this paper
• Verification of quantitative analytical methods in medical laboratories

  2020cites this paper
• Standardized biomarker and biobanking requirements for personalized psychiatry

  2020cites this paper
• Analysis of mutant and total huntingtin expression in Huntington’s disease murine models

  2020cites this paper
• Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus

  2020cites this paper
• Intact Protein Mass Spectrometry for Therapeutic Protein Quantitation, Pharmacokinetics and Biotransformation in Pre-Clinical and Clinical Studies: An Industry Perspective.

  2020cites this paper
• Intact mAb LC-MS for drug concentration from pre-clinical studies: bioanalytical method performance and in-life samples.

  2020cites this paper
• Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA

  2020cites this paper
• A guided approach to preclinical bioanalysis of proteins using immunoassays for pharmacokinetic and pharmacodynamic assessments.

  2020cites this paper
• Development and validation of ELISAs for the quantitation of interleukin (IL)-1β, IL-6, IL-8 and IL-10 in ovine plasma.

  2020cites this paper
• Rapid identification of anti-idiotypic mAbs with high affinity and diverse epitopes by rabbit single B-cell sorting-culture and cloning technology

  2020cites this paper
• Production of monoclonal antibodies for measuring Avastin and its biosimilar by Sandwich ELISA.

  2019cites this paper
• Biomarker Assay Development, Qualification, and Validation

  2019cites this paper
• Développement et validation de méthodes de protéomique innovantes pour des applications de biochimie clinique

  2019cites this paper
• Serum Cobalamin and Folate Concentrations in Common Marmosets (Callithrix jacchus) with Chronic Lymphocytic Enteritis.

  2019cites this paper
• Development and validation of an LC-MS/MS method for detection and quantification of in vivo derived metabolites of [Pyr1]apelin-13 in humans

  2019cites this paper
• Current Perspectives on Ligand-Binding Assay Practices in the Quantification of Circulating Therapeutic Proteins for Biosimilar Biological Product Development

  2019cites this paper
• Development and validation of a noncompetitive electrochemiluminescence-based immunoassay (ECLIA) for specific determination of insulin lispro (Humalog®) in human serum to support pharmacokinetic assessments

  2019cites this paper
• Exploratory biomarker assays: key assay parameters to evaluate in the face of evolving biomarker context-of-use.

  2019cites this paper
• Mesencephalic Astrocyte-Derived Neurotrophic Factor Is Upregulated with Therapeutic Fasting in Humans and Diet Fat Withdrawal in Obese Mice

  2019cites this paper
• Pharmacokinetic Similarity of ABP 710, a Proposed Biosimilar to Infliximab: Results From a Randomized, Single‐Blind, Single‐Dose, Parallel‐Group Study in Healthy Subjects

  2019cites this paper
• Certified reference material against PR3 ANCA IgG autoantibodies. From development to certification

  2019cites this paper
• Design of Experiments As a Tool for Optimization in Recombinant Protein Biotechnology: From Constructs to Crystals

  2019cites this paper
• Copper and selenium status as biomarkers of neonatal infections.

  2019cites this paper